These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17517919)

  • 21. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
    Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
    Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR mapping of the IFNAR1-EC binding site on IFNalpha2 reveals allosteric changes in the IFNAR2-EC binding site.
    Akabayov SR; Biron Z; Lamken P; Piehler J; Anglister J
    Biochemistry; 2010 Feb; 49(4):687-95. PubMed ID: 20047337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
    Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
    Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
    Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
    J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface.
    Piehler J; Roisman LC; Schreiber G
    J Biol Chem; 2000 Dec; 275(51):40425-33. PubMed ID: 10984492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1.
    de Weerd NA; Vivian JP; Nguyen TK; Mangan NE; Gould JA; Braniff SJ; Zaker-Tabrizi L; Fung KY; Forster SC; Beddoe T; Reid HH; Rossjohn J; Hertzog PJ
    Nat Immunol; 2013 Sep; 14(9):901-7. PubMed ID: 23872679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
    Cutrone EC; Langer JA
    J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
    Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
    J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2.
    Schmeisser H; Gorshkova I; Brown PH; Kontsek P; Schuck P; Zoon KC
    Biochemistry; 2007 Dec; 46(50):14638-49. PubMed ID: 18027911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
    Lamken P; Lata S; Gavutis M; Piehler J
    J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the murine alpha interferon gene family.
    van Pesch V; Lanaya H; Renauld JC; Michiels T
    J Virol; 2004 Aug; 78(15):8219-28. PubMed ID: 15254193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs.
    Zhao W; Lee C; Piganis R; Plumlee C; de Weerd N; Hertzog PJ; Schindler C
    J Immunol; 2008 Apr; 180(8):5483-9. PubMed ID: 18390731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
    Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
    Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo design of nonpeptidic compounds targeting the interactions between interferon-alpha and its cognate cell surface receptor.
    Bello AM; Bende T; Wei L; Wang X; Majchrzak-Kita B; Fish EN; Kotra LP
    J Med Chem; 2008 May; 51(9):2734-43. PubMed ID: 18393399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of IFN-alpha2 and IFN-alpha8 exhibits synergistic antiproliferative activity on renal cell carcinoma (RCC) cell lines through increased binding affinity for IFNAR-2.
    Tanimoto T; Yamamoto S; Taniai M; Taniguchi M; Ariyasu H; Ushio C; Aga M; Mukai Y; Tsutsumi Y; Ariyasu T; Ohta T; Fukuda S
    J Interferon Cytokine Res; 2007 Jun; 27(6):517-23. PubMed ID: 17572016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.
    Quadt-Akabayov SR; Chill JH; Levy R; Kessler N; Anglister J
    Protein Sci; 2006 Nov; 15(11):2656-68. PubMed ID: 17001036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cDNA cloning, genomic structure and mRNA expression pattern of porcine type I interferons receptor 2 gene.
    Xing F; Li Y; Liang S; Liu D; Jiang C; Zhang Y; Kang L; Jiang Y
    Int J Immunogenet; 2011 Aug; 38(4):339-45. PubMed ID: 21649860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of IFNAR1 mRNA expression in multiple sclerosis patients.
    Serana F; Sottini A; Ghidini C; Zanotti C; Capra R; Cordioli C; Caimi L; Imberti L
    J Neuroimmunol; 2008 Jun; 197(1):54-62. PubMed ID: 18482773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule mimetics of an interferon-α receptor interacting domain.
    Bello AM; Wei L; Majchrzak-Kita B; Salum N; Purohit MK; Fish EN; Kotra LP
    Bioorg Med Chem; 2014 Feb; 22(3):978-85. PubMed ID: 24433965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S27 of IFNα1 Contributes to Its Low Affinity for IFNAR2 and Weak Antiviral Activity.
    Sharma N; O'Neal AJ; Gonzalez C; Wittling M; Gjinaj E; Parsons LM; Panda D; Khalenkov A; Scott D; Misra S; Rabin RL
    J Interferon Cytokine Res; 2019 May; 39(5):283-292. PubMed ID: 30920934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.